StockNews.AI
BDX
StockNews.AI
111 days

BD to Present at Bank of America Securities Health Care Conference

1. BDX will present at the Bank of America Health Care Conference. 2. The presentation is scheduled for May 13, 2025. 3. BDX is a leading global medical technology company. 4. They focus on medical discovery, diagnostics, and care delivery. 5. BDX employs over 70,000 people globally.

3m saved
Insight
Article

FAQ

Why Bullish?

Presentations at major conferences often lead to positive investor sentiment. Historical examples show stock rises post-announcement of conference participations when innovation is highlighted.

How important is it?

Conference visibility can attract attention to BDX’s innovations, influencing market confidence. Positive sentiment often correlates with short-term stock price movements.

Why Short Term?

The conference is upcoming, likely affecting BDX's stock price in the immediate future. Past trends indicate short-term price movements in response to positive news.

Related Companies

BD Announces Presentation at Bank of America Securities Health Care Conference

FRANKLIN LAKES, N.J., April 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of America Securities Health Care Conference on Tuesday, May 13, 2025 at 1:00 pm Eastern Time.

The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com. A replay of the event will be available on the same webpage following its conclusion.

About BD

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.

For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.

Contacts:

Media:

Troy Kirkpatrick
VP, Public Relations
858.617.2361
tkirkpatrick@bd.com

Investors:

Adam Reiffe
Sr. Director, Investor Relations
201.847.6927
areiffe@bd.com

SOURCE BD (Becton, Dickinson and Company)

Related News